Anxiety and depressive disorders in patients with primary painful bladder syndrome. Part 2. Modern treatment approaches

Abstract

This article presents modern approaches to the treatment of comorbid anxiety and depressive disorders in patients with primary painful bladder syndrome. The pharmacotherapy options and various non-pharmacological methods (psychotherapy, cognitive-behavioral therapy, hypnotherapy) for managing these conditions are detailed. It is noted that treatment targeting only the physical component of chronic pelvic pain is often ineffective. To achieve the desired outcome in some patients, it is also necessary to address cognitive, emotional, and behavioral factors associated with pain syndrome.

Keywords

depression / anxiety disorders / comorbidity / somatoform disorders / painful bladder syndrome / psychotherapy / cognitive-behavioral therapy

References

[1] Engeler D, Baranowski AP, Bergmans B, et al. EAU guidelines on chronic pelvic pain. European Association of Urology Guideline. 2024. Available from: https://uroweb.org/guidelines/chronic-pelvic-pain

[2] Engeler D., Baranowski A.P., Bergmans B., et al. EAU guidelines on chronic pelvic pain. European Association of Urology Guideline. 2024. Режим доступа: https://uroweb.org/guidelines/chronic-pelvic-pain Дата обращения: 28.12.2024.

[3] Homma Y, Akiyama Y, Tomoe H, et al. Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int J Urol. 2020;27(7): 578–589. doi: 10.1111/iju.14234

[4] Homma Y., Akiyama Y., Tomoe H., et al. Clinical guidelines for interstitial cystitis/bladder pain syndrome // Int J Urol. 2020. Vol. 27. N 7. P. 578–589. doi: 10.1111/iju.14234

[5] Slesarevskaya MN, Ignashov YuA, Kuzmin IV, Al-Shukri SKh. Persistent dysuria in women: etiological diagnosis and treatment. Urological Reports (St. Petersburg). 2021;11(3):195–204. EDN: BDUFWQ doi: 10.17816/uroved81948

[6] Слесаревская М.Н., Игнашов Ю.А., Кузьмин И.В., Аль-Шукри С.Х. Стойкая дизурия у женщин: этиологическая диагностика и лечение // Урологические ведомости. 2021. Т. 11, № 3. С. 195–204. EDN: BDUFWQ doi: 10.17816/uroved81948

[7] Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208(1):34–42. doi: 10.1097/JU.0000000000002756

[8] Clemens J.Q., Erickson D.R., Varela N.P., Lai H.H. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome // J Urol. 2022. Vol. 208, N 1. P. 34–42. EDN: VCOIGB doi: 10.1097/JU.0000000000002756

[9] Slesarevskaya MN, Ignashov YuA, Kuzmin IV. Current approaches to the diagnostic of bladder pain syndrome. Urological Reports (St. Petersburg). 2017;7(2):25–30. EDN: YUCBMP doi: 10.17816/uroved7225-3

[10] Слесаревская М.Н., Игнашов Ю.А., Кузьмин И.В. Современные подходы к диагностике синдрома болезненного мочевого пузыря // Урологические ведомости 2017. Т. 7, № 2. С. 25–30. EDN: YUCBMP doi: 10.17816/uroved7225-3

[11] Juliebø-Jones P, Hjelle KM, Mohn J, et al. Management of bladder pain syndrome (BPS): a practical guide. Adv Urol. 2022;2022:7149467. doi: 10.1155/2022/7149467

[12] Juliebø-Jones P., Hjelle K.M., Mohn J., et al. Management of bladder pain syndrome (BPS): A Practical Guide // Adv Urol. 2022. Vol. 2022. P. 7149467. doi: 10.1155/2022/7149467

[13] Zaitsev AV, Sharov MN, Ibragimov RA, et al. Painful bladder syndrome / interstitial cystitis: modern approaches to diagnosis and treatment. Vrach Skoroi Pomoshchi. 2018;(8):16–26. (In Russ.) EDN: YLJJWX

[14] Зайцев А.В., Шаров М.Н., Ибрагимов Р.А., и др. Синдром болезненного мочевого пузыря/интерстициальный цистит: современные подходы к диагностике и лечению // Врач скорой помощи. 2018. № 8. С. 16–26. EDN: YLJJWX

[15] Al-Shukri SH, Kuzmin IV, Slesarevskaya MN, Ignashov YuA. Bladder hydrodistension in the treatment of patients with interstitial cystitis/painful bladder syndrome. Urologiia. 2018;(1):26–29. EDN: YRSGPY doi: 10.18565/urology.2018.1.26-29

[16] Аль-Шукри С.Х., Кузьмин И.В., Слесаревская М.Н., Игнашов Ю.А. Гидродистензия мочевого пузыря в лечении больных интерстициальным циститом/синдромом болезненного мочевого пузыря // Урология. 2018. № 1. С. 26–29. EDN: YRSGPY doi: 10.18565/urology.2018.1.26–29

[17] Riegel B, Bruenahl CA, Ahyai S, et al. Assessing psychological factors, social aspects, and psychiatric co-morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men — a systematic review. J Psychosom Res. 2014;77(5):333–350. doi: 10.1016/j.jpsychores.2014.09.012

[18] Riegel B., Bruenahl C.A., Ahyai S., et al. Assessing psychological factors, social aspects and psychiatric co-morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men — a systematic review // J Psychosomatic Research. 2014. Vol. 77, N 5. P. 333–350. doi: 10.1016/j.jpsychores.2014.09.012

[19] Brünahl C, Dybowski C, Albrecht R, et al. Mental disorders in patients with chronic pelvic pain syndrome (CPPS). J Psychosom Res. 2017;98:19–26. doi: 10.1016/j.jpsychores

[20] Brünahl C., Dybowski C., Albrecht R., et al. Mental disorders in patients with chronic pelvic pain syndrome (CPPS) // J Psychosom Res. 2017. Vol. 98. P. 19–26. doi: 10.1016/j.jpsychores

[21] Fedorova AI, Vykhodtsev SV, Tregubenko IA. Pathogenetic features of psychosomatic disorders of the urogenital sphere of men and women. Psychiatry (Moscow). 2022;20(S3(2)):112–113. EDN: QAEKJG

[22] Федорова А.И., Выходцев С.В., Трегубенко И.А. Патогенетические особенности психосоматических расстройств урогенитальной сферы мужчин и женщин // Психиатрия. 2022. Т. 20, № S3(2). С. 112–113. EDN: QAEKJG

[23] Thompson EL, Broadbent J, Fuller-Tyszkiewicz M, et al. A network analysis of the links between chronic pain symptoms and affective disorder symptoms. Int J Behav Med. 2019;26(1):59–68. doi: 10.1007/s12529-018-9754-8

[24] Thompson E.L., Broadbent J., Fuller-Tyszkiewicz M., et al. A network analysis of the links between chronic pain symptoms and affective disorder symptoms // Int J Behav Med. 2019. Vol. 26, N 1. P. 59–68. doi: 10.1007/s12529-018-9754-8 EDN: RDZKLE

[25] Slesarevskaya MN, Kuzmin IV, Ignashov YuA Features of symptomatology and psychoemotional status in women with chronic pelvic pain syndrome. Urological Reports (St. Petersburg). 2015;5(3): 16–19. EDN: VHUCAT doi: 10.17816/uroved5316-19

[26] Слесаревская М.Н., Кузьмин И.В., Игнашов Ю.А. Особенности симптоматики и психоэмоционального статуса у женщин с синдромом хронической тазовой боли // Урологические ведомости. 2015. Т. 5, № 3. C. 16–19. EDN: VHUCAT doi: 10.17816/uroved5316–19

[27] Wi D, Park C, Ransom JC, et al. A network analysis of pain intensity and pain-related measures of physical, emotional, and social functioning in US military service members with chronic pain. Pain Med. 2024;25(3):231–238. doi: 10.1093/pm/pnad148

[28] Wi D., Park C., Ransom J.C., et al. A network analysis of pain intensity and pain-related measures of physical, emotional, and social functioning in US military service members with chronic pain // Pain Med. 2024. Vol. 25, N 3. P. 231–238. doi: 10.1093/pm/pnad148

[29] Kryuchkova MN, Soldatkin VA. Chronic pelvic pain syndrome: psychopathological aspects. Urology Herald. 2017;5(1):52–63. EDN: YHGGNN doi: 10.21886/2306-6424-2017-5-1-52-63

[30] Крючкова М.Н., Солдаткин В.А. Синдром хронической тазовой боли: психопатологические аспекты // Вестник урологии. 2017. Т. 5, № 1. C. 52–63. EDN: YHGGNN doi: 10.21886/2306-6424-2017-5-1-52-63

[31] Karavaeva TA, Vasilieva AV, Kuzmin IV, et al. Anxiety and depressive disorders in patients with primary painful bladder syndrome. Part 1: symptoms and clinical progression. Urological Reports (St. Petersburg). 2024;14(3):331–342. EDN: JEBVHE doi: 10.17816/uroved635373

[32] Караваева Т.А., Васильева А.В., Кузьмин И.В., и др. Тревожные и депрессивные расстройства у пациентов с первичным синдромом болезненного мочевого пузыря. Часть 1. Симптоматика и клиническое течение // Урологические ведомости. 2024. Т. 14, № 3. C. 331–342. EDN: JEBVHE doi: 10.17816/uroved635373

[33] Sandler MD, Ledesma B, Thomas J, et al. Biopsychosocial approach to male chronic pelvic pain syndrome: recent treatments and trials. Sex Med Rev. 2023;12(1):59–66. doi: 10.1093/sxmrev/qead038

[34] Sandler M.D., Ledesma B., Thomas J., et al. Biopsychosocial approach to male chronic pelvic pain syndrome: recent treatments and trials // Sex Med Rev. 2023. Vol. 12, N 1. P. 59–66. doi: 10.1093/sxmrev/qead038

[35] Coelho DRA, Gersten M, Jimenez AS, et al. Treating neuropathic pain and comorbid affective disorders: preclinical and clinical evidence. Pain Pract. 2024;24(7):937–955. doi: 10.1111/papr.13370

[36] Coelho D.R.A., Gersten M., Jimenez A.S., et al. Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence // Pain Pract. 2024. Vol. 24, N 7. P. 937–955. doi: 10.1111/papr.13370

[37] Vasilieva AV, Karavaeva TA, Neznanov NG. Psychotherapy in somatic medicine. In: Psychotherapy: National Guide. Vasilieva AV, Karavaeva TA, Neznanov NG, editors. Moscow: GEOTAR-Media; 2023. P. 928–938. (In Russ.)

[38] Васильева А.В., Караваева Т.А., Незнанов Н.Г. Психотерапия в соматической медицине. В кн.: Психотерапия: национальное руководство / под ред. А.В. Васильевой, Т.А. Караваевой, Н.Г. Незнанова. Москва: ГЭОТАР-Медиа, 2023. С. 928–938.

[39] Haase J, Brown E. Integrating the monoamine, neurotrophin, and cytokine hypotheses of depression — a central role for the serotonin transporter? Pharmacol Ther. 2015;147:1–11. doi: 10.1016/j.pharmthera.2014.10.002

[40] Haase J., Brown E. Integrating the monoamine, neurotrophin and cytokine hypotheses of depression — a central role for the serotonin transporter? // Pharmacol Ther. 2015. Vol. 147. P. 1–11. doi: 10.1016/j.pharmthera.2014.10.002

[41] Zhuo M. Neural mechanisms underlying anxiety-chronic pain interactions. Trends Neurosci. 2016;39(3):136–145. doi: 10.1016/j.tins.2016.01.006

[42] Zhuo M. Neural mechanisms underlying anxiety-chronic pain interactions // Trends Neurosci. 2016. Vol. 39, N 3. P. 136–145. doi: 10.1016/j.tins.2016.01.006

[43] Hebert SV, Green MA, Mashaw SA, et al. Assessing risk factors and comorbidities in the treatment of chronic pain: a narrative review. Curr Pain Headache Rep. 2024;28(6):525–534. doi: 10.1007/s11916-024-01249-z

[44] Hebert S.V., Green M.A., Mashaw S.A., et al. Assessing risk factors and comorbidities in the treatment of chronic pain: a narrative review // Curr Pain Headache Rep. 2024. Vol. 28, N 6. P. 525–534. doi: 10.1007/s11916-024-01249-z

[45] Foster HE Jr, Hanno PM, Nickel JC, et al. Effect of amitriptyline on symptoms in treatment-naive patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1853–1858. doi: 10.1016/j.juro.2009.12.106

[46] Foster H.E. Jr., Hanno P.M., Nickel J.C., et al. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome // J Urol. 2010. Vol. 183, N 5. P. 1853–1858. doi: 10.1016/j.juro.2009.12.106

[47] Van Ophoven A, Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study. J Urol. 2007;177(2):552–555. doi: 10.1016/j.juro.2006.09.055

[48] Van Ophoven A., Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study // J Urol. 2007. Vol. 177. N 2. P. 552–555. doi: 10.1016/j.juro.2006.09.055

[49] Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiatry. 2010;81(12): 1372–1373. doi: 10.1136/jnnp.2008.144964

[50] Saarto T., Wiffen P.J. Antidepressants for neuropathic pain: a Cochrane review // J Neurol Neurosurg Psychiatry. 2010. Vol. 81, N 12. P. 1372–1373. doi: 10.1136/jnnp.2008.144964

[51] Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev. 2009;4: CD007115. doi: 10.1002/14651858.CD007115.pub2

[52] Lunn M.P., Hughes R.A., Wiffen P.J. Duloxetine for treating painful neuropathy or chronic pain // Cochrane Database Syst Rev. 2009. Vol. 4. P. CD007115. doi: 10.1002/14651858.CD007115.pub2

[53] Aktar N, Moudud A, Chen T, et al. Recent advances in pharmacological interventions of chronic prostatitis/chronic pelvic pain syndrome. Curr Pharm Des. 2021;27(25):2861–2871. doi: 10.2174/1381612827666210322125054

[54] Aktar N., Moudud A., Chen T., et al. Recent advances in pharmacological interventions of chronic prostatitis/ chronic pelvic pain syndrome // Curr Pharm Des. 2021. Vol. 27, N 25. P. 2861–2871. doi: 10.2174/1381612827666210322125054

[55] Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;3: CD007076. doi: 10.1002/14651858.CD007076.pub2

[56] Moore R.A., Straube S., Wiffen P.J., et al. Pregabalin for acute and chronic pain in adults // Cochrane Database Syst Rev. 2009. Vol. 3. P. CD007076. doi: 10.1002/14651858.CD007076.pub2

[57] Franco JVA, Turk T, Jung JH, et al. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review. BJU Int. 2020;125(4):490–496. doi: 10.1111/bju.14988

[58] Franco J.V.A., Turk T., Jung J.H., et al. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review // BJU Int. 2020. Vol. 125, N 4. P. 490–496. doi: 10.1111/bju.14988

[59] Allaire C, Yong PJ, Bajzak K, Jarrell J, et al. Guideline No. 445: Management of chronic pelvic pain. J Obstet Gynaecol Can. 2024;46(1):102283. doi: 10.1016/j.jogc.2023.102283

[60] Allaire C., Yong P.J., Bajzak K., Jarrell J., et al. Guideline No. 445: management of chronic pelvic pain // J Obstet Gynaecol Can. 2024. Vol. 46, N 1. P. 102283. doi: 10.1016/j.jogc.2023.102283

[61] Servais L, Huberland V, Richelle L. Misuse of pregabalin: a qualitative study from a patient’s perspective. BMC Public Health. 2023;23(1):1339. doi: 10.1186/s12889-023-16051-6

[62] Servais L., Huberland V., Richelle L. Misuse of Pregabalin: a qualitative study from a patient’s perspective // BMC Public Health. 2023. Vol. 23, N 1. P. 1339. doi: 10.1186/s12889-023-16051-6

[63] Radionov DS, Karavaeva TA, Vasilieva FV, et al. Peculiarities of alcohol abuse by individuals with neurotic spectrum anxiety disorders. Clinical aspects and issues of psychotherapy. Journal of Addiction Problems. 2023;35(3):27–50. EDN: AQBTRS

[64] Радионов Д.С., Караваева Т.А., Васильева Ф.В., и др. Особенности злоупотребления алкоголем у лиц с тревожными расстройствами невротического спектра. Клинические аспекты и вопросы психотерапии // Вопросы наркологии. 2023. Т. 35, № 3. С. 27–50. EDN: AQBTRS

[65] Urits I, Callan J, Moore WC, et al. Cognitive behavioral therapy for the treatment of chronic pelvic pain. Best Pract Res Clin Anaesthesiol. 2020;34(3):409–426. doi: 10.1016/j.bpa.2020.08.001

[66] Urits I., Callan J., Moore W.C., et al. Cognitive behavioral therapy for the treatment of chronic pelvic pain // Best Pract Res Clin Anaesthesiol. 2020. Vol. 34, N 3. P. 409–426. doi: 10.1016/j.bpa.2020.08.001

[67] Sanabria-Mazo JP, Colomer-Carbonell A, Fernández-Vázquez Ó, et al. A systematic review of cognitive behavioral therapy-based interventions for comorbid chronic pain and clinically relevant psychological distress. Front Psychol. 2023;14:1200685. doi: 10.3389/fpsyg.2023.1200685

[68] Sanabria-Mazo J.P., Colomer-Carbonell A., Fernández-Vázquez Ó., et al. A systematic review of cognitive behavioral therapy-based interventions for comorbid chronic pain and clinically relevant psychological distress // Front Psychol. 2023. Vol. 14. P. 1200685. doi: 10.3389/fpsyg.2023.1200685

[69] Martinson A, Johanson K, Wong S. Examining the efficacy of a brief cognitive-behavioral therapy for chronic pain (Brief CBT-CP) group delivered via VA Video Connect (VVC) among older adult veterans. Clin Gerontol. 2024;47(1):122–135. doi: 10.1080/07317115.2023.2186303

[70] Martinson A., Johanson K., Wong S. Examining the efficacy of a brief cognitive-behavioral therapy for chronic pain (Brief CBT-CP) group delivered via VA Video connect (VVC) among older adult veterans // Clin Gerontol. 2024. Vol. 47, N 1. P. 122–135. doi: 10.1080/07317115.2023.2186303

[71] Zambelli Z, Halstead EJ, Fidalgo AR, et al. Telehealth delivery of adapted CBT-I for insomnia in chronic pain patients: a single-arm feasibility study. Front Psychol. 2024;14:1266368. doi: 10.3389/fpsyg.2023.1266368

[72] Zambelli Z., Halstead E.J., Fidalgo A.R., et al. Telehealth delivery of adapted CBT-I for insomnia in chronic pain patients: a single arm feasibility study // Front Psychol. 2024. Vol. 14. P. 1266368. doi: 10.3389/fpsyg.2023.1266368

[73] Moreno-Ligero M, Moral-Munoz JA, Salazar A, et al. mHealth intervention for improving pain, quality of life, and functional disability in patients with chronic pain: systematic review. JMIR Mhealth Uhealth. 2023;11:e40844. doi: 10.2196/40844

[74] Moreno-Ligero M., Moral-Munoz J.A., Salazar A., et al. Health Intervention for improving pain, quality of life, and functional disability in patients with chronic pain: systematic review // JMIR Mhealth Uhealth. 2023. Vol. 11. P. e40844. doi: 10.2196/40844

[75] Mazzolenis MV, Mourra GN, Moreau S, et al. The role of virtual reality and artificial intelligence in cognitive pain therapy: a narrative review. Curr Pain Headache Rep. 2024. doi: 10.1007/s11916-024-01270-2

[76] Mazzolenis M.V., Mourra G.N., Moreau S., et al. The role of virtual reality and artificial intelligence in cognitive pain therapy: a narrative review // Curr Pain Headache Rep. 2024. doi: 10.1007/s11916-024-01270-2

[77] Wagner B, Steiner M, Huber DFX, et al. The effect of biofeedback interventions on pain, overall symptoms, quality of life, and physiological parameters in patients with pelvic pain: a systematic review. Wien Klin Wochenschr. 2022;134(Suppl 1):11–48. doi: 10.1007/s00508-021-01827-w

[78] Wagner B., Steiner M., Huber D.F.X., et al. The effect of biofeedback interventions on pain, overall symptoms, quality of life and physiological parameters in patients with pelvic pain: A systematic review. Wien Klin Wochenschr. 2022. Vol. 134 (Suppl 1). P. 11–48. doi: 10.1007/s00508-021-01827-w

[79] Cornel EB, van Haarst EP, Schaarsberg RW, et al. The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Eur Urol. 2005;5:607–611. doi: 10.1016/j.eururo.2004.12.014

[80] Cornel E.B., van Haarst E.P., Schaarsberg R.W., et al. The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III // Eur Urol. 2005. N 5. P. 607–611. doi: 10.1016/j.eururo.2004.12.014

[81] Borrego-Jimenez PS, Flores-Fraile J, Padilla-Fernández BY, et al. Improvement in quality of life with pelvic floor muscle training and biofeedback in patients with painful bladder syndrome/interstitial cystitis. J Clin Med. 2021;10(4):862. doi: 10.3390/jcm10040862

[82] Borrego-Jimenez P.S., Flores-Fraile J., Padilla-Fernández B.Y., et al. Improvement in quality of life with pelvic floor muscle training and biofeedback in patients with painful bladder syndrome/interstitial cystitis // J Clin Med. 2021. Vol. 10, N 4. P. 862. doi: 10.3390/jcm10040862

[83] Trindade IA, Guiomar R, Carvalho SA. Efficacy of online-based acceptance and commitment therapy for chronic pain: a systematic review and meta-analysis. J Pain. 2021;22(11):1328–1342. doi: 10.1016/j.jpain.2021.04.003

[84] Trindade I.A., Guiomar R., Carvalho S.A. Efficacy of online-based acceptance and commitment therapy for chronic pain: a systematic review and meta-analysis // J Pain. Vol. 22, N 11. P. 1328–1342. doi: 10.1016/j.jpain.2021.04.003

[85] McCracken LM, Vowles KE. Acceptance and commitment therapy and mindfulness for chronic pain: model, process, and progress. Am Psychol. 2014;2:178–187. doi: 10.1037/a0035623

[86] McCracken L.M., Vowles K.E. Acceptance and commitment therapy and mindfulness for chronic pain: model, process, and progress // Am Psychol. 2014. N 2. P. 178–187. doi: 10.1037/a0035623

[87] Ye L, Li Y, Deng Q, et al. Acceptance and commitment therapy for patients with chronic pain: a systematic review and meta-analysis on psychological outcomes and quality of life. PLoS One. 2024;19(6): e0301226. doi: 10.1371/journal.pone.0301226

[88] Ye L., Li Y., Deng Q., et al. Acceptance and commitment therapy for patients with chronic pain: A systematic review and meta-analysis on psychological outcomes and quality of life // PLoS One. 2024. Vol. 19, N 6. P. e0301226. doi: 10.1371/journal.pone.0301226

[89] Herbert MS, Dochat C, Wooldridge JS, et al. Technology-supported acceptance and commitment therapy for chronic health conditions: a systematic review and meta-analysis. Behav Res Ther. 2022;148:103995. doi: 10.1016/j.brat.2021

[90] Herbert M.S., Dochat C., Wooldridge J.S., et al. Technology-supported acceptance and commitment therapy for chronic health conditions: a systematic review and meta-analysis // Behav Res Ther. 2022. Vol. 148. P. 103995. doi: 10.1016/j.brat.2021

[91] Langlois P, Perrochon A, David R, et al. Hypnosis to manage musculoskeletal and neuropathic chronic pain: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;135:104591. doi: 10.1016/j.neubiorev.2022.104591

[92] Langlois P., Perrochon A., David R., et al. Hypnosis to manage musculoskeletal and neuropathic chronic pain: A systematic review and meta-analysis // Neurosci Biobehav Rev. 2022. Vol. 135. P. 104591. doi: 10.1016/j.neubiorev.2022.104591

[93] Caron-Trahan R, Jusseaux AE, Aubin M, et al. Practicing self-hypnosis to reduce chronic pain: a qualitative exploratory study of HYlaDO. Br J Pain. 2024;18(1):28–41. doi: 10.1177/20494637231200324

[94] Caron-Trahan R., Jusseaux A.E., Aubin M., et al. Practicing self-hypnosis to reduce chronic pain: A qualitative exploratory study of HYlaDO // Br J Pain. 2024. Vol. 18, N 1. P. 28–41. doi: 10.1177/20494637231200324

[95] Adachi T, Fujino H, Nakae A, et al. A meta-analysis of hypnosis for chronic pain problems: a comparison between hypnosis, standard care, and other psychological interventions. Int J Clin Exp Hypn. 2014;62(1):1–28. doi: 10.1080/00207144.2013.841471

[96] Adachi T., Fujino H., Nakae A., et al. A meta-analysis of hypnosis for chronic pain problems: a comparison between hypnosis, standard care, and other psychological interventions // Int J Clin Exp Hypn. 2014. Vol. 62, N 1. P. 1–28. doi: 10.1080/00207144.2013.841471

[97] Thompson T, Terhune DB, Oram C, et al. The effectiveness of hypnosis for pain relief: a systematic review and meta-analysis of 85 controlled experimental trials. Neurosci Biobehav Rev. 2019;99:298–310. doi: 10.1016/j.neubiorev.2019.02.013

[98] Thompson T., Terhune D.B., Oram C., et al. The effectiveness of hypnosis for pain relief: A systematic review and meta-analysis of 85 controlled experimental trials // Neurosci Biobehav Rev. 2019. Vol. 99. P. 298–310. doi: 10.1016/j.neubiorev.2019.02.013

Funding

ФГБУ «НМИЦ ПН им. В.М. Бехтерева» Минздрава России на 2024–2026 гг.V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology for 2024–2026(XSOZ 2024 0014)

RIGHTS & PERMISSIONS

Eco-Vector